Alissa Huston
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Multiple Myeloma | 4 | 2006 | 44 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2006 | 11 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 58 |
Why?
|
Neutropenia | 1 | 2007 | 42 |
Why?
|
Bone Marrow | 1 | 2008 | 109 |
Why?
|
Bone Diseases | 1 | 2006 | 23 |
Why?
|
Breast Neoplasms | 5 | 2008 | 186 |
Why?
|
Bone Density Conservation Agents | 2 | 2009 | 26 |
Why?
|
Lactams, Macrocyclic | 2 | 2006 | 10 |
Why?
|
Benzoquinones | 2 | 2006 | 14 |
Why?
|
Antineoplastic Agents | 2 | 2007 | 191 |
Why?
|
Cell Line, Tumor | 3 | 2006 | 209 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2011 | 14 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 28 |
Why?
|
Acupressure | 1 | 2010 | 8 |
Why?
|
Vitamin D | 1 | 2011 | 42 |
Why?
|
Osteoporotic Fractures | 1 | 2009 | 11 |
Why?
|
Cell Cycle | 2 | 2006 | 121 |
Why?
|
Calcitriol | 1 | 2009 | 29 |
Why?
|
Osteoporosis | 1 | 2009 | 47 |
Why?
|
Nausea | 1 | 2010 | 34 |
Why?
|
Genes, BRCA2 | 1 | 2008 | 9 |
Why?
|
Genes, BRCA1 | 1 | 2008 | 12 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2008 | 8 |
Why?
|
Phosphorylcholine | 1 | 2008 | 11 |
Why?
|
Macrophages | 1 | 2011 | 148 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 1 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2007 | 3 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 18 |
Why?
|
Genetic Testing | 1 | 2008 | 49 |
Why?
|
Humans | 11 | 2006 | 1858 |
Why?
|
Receptors, Retinoic Acid | 1 | 2007 | 19 |
Why?
|
Anemia | 1 | 2008 | 60 |
Why?
|
Tumor Markers, Biological | 1 | 2010 | 112 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 34 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 53 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 64 |
Why?
|
Sirolimus | 1 | 2006 | 25 |
Why?
|
DNA Replication | 1 | 2008 | 76 |
Why?
|
Environment | 1 | 2006 | 43 |
Why?
|
Protein Kinases | 1 | 2006 | 64 |
Why?
|
Cell Survival | 1 | 2008 | 230 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 132 |
Why?
|
Flow Cytometry | 1 | 2008 | 216 |
Why?
|
Cell Division | 1 | 2008 | 273 |
Why?
|
Inflammation | 1 | 2008 | 208 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 121 |
Why?
|
Bone Density | 2 | 2009 | 62 |
Why?
|
Female | 6 | 2008 | 1646 |
Why?
|
Middle Aged | 4 | 2008 | 1166 |
Why?
|
Retrospective Studies | 2 | 2010 | 656 |
Why?
|
Aged | 3 | 2008 | 992 |
Why?
|
Cell Differentiation | 2 | 2006 | 262 |
Why?
|
Tumor Microenvironment | 1 | 2011 | 10 |
Why?
|
Adult | 3 | 2008 | 1321 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 27 |
Why?
|
Suggestion | 1 | 2010 | 7 |
Why?
|
Relaxation Therapy | 1 | 2010 | 12 |
Why?
|
Animals | 1 | 2007 | 1032 |
Why?
|
Receptor, erbB-2 | 1 | 2010 | 25 |
Why?
|
Immune Tolerance | 1 | 2011 | 72 |
Why?
|
Neovascularization, Pathologic | 1 | 2011 | 64 |
Why?
|
Vomiting | 1 | 2010 | 45 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 44 |
Why?
|
Monocytes | 1 | 2011 | 124 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 189 |
Why?
|
Patient Education as Topic | 1 | 2010 | 128 |
Why?
|
Disease Progression | 1 | 2011 | 244 |
Why?
|
Ovariectomy | 1 | 2008 | 23 |
Why?
|
Life Expectancy | 1 | 2008 | 20 |
Why?
|
Case-Control Studies | 1 | 2011 | 284 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 193 |
Why?
|
Monte Carlo Method | 1 | 2008 | 40 |
Why?
|
Mastectomy | 1 | 2008 | 26 |
Why?
|
Models, Economic | 1 | 2008 | 14 |
Why?
|
Markov Chains | 1 | 2008 | 25 |
Why?
|
Ferritins | 1 | 2008 | 36 |
Why?
|
Quality-Adjusted Life Years | 1 | 2008 | 22 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 126 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 118 |
Why?
|
Interleukin-1beta | 1 | 2008 | 36 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 118 |
Why?
|
C-Reactive Protein | 1 | 2008 | 55 |
Why?
|
Prognosis | 1 | 2010 | 389 |
Why?
|
Health Care Costs | 1 | 2008 | 73 |
Why?
|
Biological Markers | 1 | 2009 | 263 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2006 | 21 |
Why?
|
T-Lymphocytes | 1 | 2011 | 182 |
Why?
|
Immunohistochemistry | 1 | 2010 | 356 |
Why?
|
Drug Synergism | 1 | 2006 | 104 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 224 |
Why?
|
Up-Regulation | 1 | 2008 | 183 |
Why?
|
Patient Satisfaction | 1 | 2008 | 120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 64 |
Why?
|
Incidence | 1 | 2008 | 337 |
Why?
|
Interleukin-6 | 1 | 2008 | 146 |
Why?
|
Neovascularization, Physiologic | 1 | 2006 | 68 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 92 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 243 |
Why?
|
Algorithms | 1 | 2008 | 226 |
Why?
|
Osteoclasts | 1 | 2006 | 48 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 210 |
Why?
|
Mutation | 1 | 2008 | 340 |
Why?
|
Treatment Outcome | 1 | 2009 | 662 |
Why?
|
Aged, 80 and over | 1 | 2008 | 602 |
Why?
|
Risk Factors | 1 | 2008 | 557 |
Why?
|
Models, Biological | 1 | 2006 | 411 |
Why?
|
Apoptosis | 1 | 2006 | 265 |
Why?
|
United States | 1 | 2008 | 604 |
Why?
|
Signal Transduction | 1 | 2006 | 313 |
Why?
|
Male | 1 | 2009 | 1558 |
Why?
|
